"The Aaron Diamond AIDS Research Center (ADARC), one of the world's largest private research center dedicated exclusively to advancing the understanding, treatment, and prevention of HIV/AIDS, joined Columbia University Irving Medical Center (CUIMC) on January 1, 2020. Dr. David Ho remains the Center’s Director and was appointed the Clyde ’56 and Helen Wu Professor of Medicine at Columbia University. He leads an expanded and diverse ADARC faculty."

During the past decade, Aaron Diamond AIDS Rsch Ctr / Rockefeller Univ conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aaron Diamond AIDS Rsch Ctr / Rockefeller Univ" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials, followed by "AIDS Clinical Trials Group" with 1 trials sponsored, "Aaron Diamond AIDS Research Center" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Glaxo Wellcome" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aaron Diamond AIDS Rsch Ctr / Rockefeller Univ" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Aaron Diamond AIDS Rsch Ctr / Rockefeller Univ" are "HIV Infections" (9 trials), "Mycobacterium Avium-Intracellulare Infection" (1 trials) and "Tuberculosis, Mycobacterium Infection" (1 trials). Many other conditions were trialed in "Aaron Diamond AIDS Rsch Ctr / Rockefeller Univ" in a lesser frequency.

Most popular intervention types in "Aaron Diamond AIDS Rsch Ctr / Rockefeller Univ" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Indinavir sulfate" (3 trials), "Abacavir sulfate" (2 trials), "Lamivudine" (2 trials), "Thalidomide" (2 trials) and "Abacavir sulfate, Lamivudine and Zidovudine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aaron Diamond AIDS Rsch Ctr / Rockefeller Univ" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Aaron Diamond AIDS Rsch Ctr / Rockefeller Univ". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Aaron Diamond AIDS Rsch Ctr / Rockefeller Univ, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Aaron Diamond AIDS Rsch Ctr / Rockefeller Univ, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".